Minireview: Dynamic Structures of Nuclear Hormone Receptors: New Promises and Challenges
Open accessThe DOI matches its Crossref record; 94 of the 94 references it cites were found in a registry or an index.
Abstract
Therapeutic targeting of nuclear receptors (NRs) is presently restricted due to 2 constraints: 1) a limited knowledge of the structural dynamics of intact receptor when complexed to DNA and coregulatory proteins; and 2) the inability to more selectively modulate NR actions at specific organ/gene targets. A major obstacle has been the current lack of understanding about the function and structure of the intrinsically disordered N-terminal domain that contains a major regulatory transcriptional activation function (AF1). Current studies of both mechanism of action and small molecule-selective receptor modulators for clinical uses target the structured pocket of the ligand-binding domain to modulate coregulatory protein interactions with the other activation function AF2. However, these approaches overlook AF1 activity. Recent studies have shown that highly flexible intrinsically disordered regions of transcription factors, including that of the N-terminal domain AF1 of NRs, not only are critical for several aspects of NR action but also can be exploited as drug targets, thereby opening unique opportunities for endocrine-based therapies. In this review article, we discuss the role of structural flexibilities in the allosteric modulation of NR activity and future perspectives for therapeutic interventions.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Two types of estrogen receptors (ERs) have been identified, the alpha (ERα) and beta (ERβ) receptors [48, 49].”
From Estrogen deficiency and the origin of obesity during menopause (2014) · cites this paper as [49]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Kitagawa, H., Yanagisawa, J., Fuse, H., Ogawa, S., Yogiashi, Y., Okuno, A., Nagasawa, H., Nakajima, T., Matsumoto, T., & Kato, S. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.11.3698-3706.2002 · Cited by 101
RetractedMolecular basis of agonism and antagonism in the oestrogen receptor
Brzozowski, A. M., Pike, A. C. W., Dauter, Z., Hubbard, R. E., Bonn, T., Engström, O., Öhman, L., Greene, G. L., Gustafsson, J.-Å., & Carlquist, M. (1997) · Nature · doi:10.1038/39645 · Cited by 3,355 · cited 1×
“Due to available LBD/AF2 crystal structures and the disordered nature of NTD/AF1, rational structure-based design of SRMs has been limited by necessity to how compounds modulate coregulatory protein interactions with AF2 (7), thereby neglecting AF1.”
BackgroundShiau, A. K., Barstad, D., Loria, P. M., Cheng, L., Kushner, P. J., Agard, D. A., & Greene, G. L. (1998) · Cell · doi:10.1016/s0092-8674(00)81717-1 · Cited by 2,729
Wright, P. E., & Dyson, H. J. (2009) · Current Opinion in Structural Biology · doi:10.1016/j.sbi.2008.12.003 · Cited by 1,019
Structure of the intact PPAR-γ–RXR-α nuclear receptor complex on DNA
Chandra, V., Huang, P., Hamuro, Y., Raghuram, S., Wang, Y., Burris, T. P., & Rastinejad, F. (2008) · Nature · doi:10.1038/nature07413 · Cited by 808 · cited 8×
“The quaternary structure of HNF-4 also indicates how 2 posttranslational modifications (Arg91 methylation and Ser78 phosphorylation) located in a unique position within the interdomain convergence zone can affect the DNA binding activity of the receptor (42).”
BackgroundMethodInfluentialIntrinsic Disorder in Transcription Factors
Liu, J., Perumal, N. B., Oldfield, C. J., Su, E. W., Uversky, V. N., & Dunker, A. K. (2006) · Biochemistry · doi:10.1021/bi0602718 · Cited by 792 · cited 1×
“In fact, most activation domains of transcription factors contain IDRs that have been refractory to crystallization (13, 14).”
BackgroundBerry, M., Metzger, D., & Chambon, P. (1990) · The EMBO Journal · doi:10.1002/j.1460-2075.1990.tb07469.x · Cited by 767 · cited 1×
“for the tissue-specific effects of the SRMs (30, 58, 59).”
BackgroundMultiple and cooperative trans-activation domains of the human glucocorticoid receptor
Hollenberg, S. M., & Evans, R. M. (1988) · Cell · doi:10.1016/0092-8674(88)90145-6 · Cited by 684
DNA binding site sequence directs glucocorticoid receptor structure and activity
Meijsing, S. H., Pufall, M. A., So, A. Y., Bates, D. L., Chen, L., & Yamamoto, K. R. (2009) · Science · doi:10.1126/science.1164265 · Cited by 673
Estrogen Receptor-Associated Proteins: Possible Mediators of Hormone-Induced Transcription
Halachmi, S., Marden, E., Martin, G., MacKay, H., Abbondanza, C., & Brown, M. (1994) · Science · doi:10.1126/science.8197458 · Cited by 637
Cited by
Estrogen deficiency and the origin of obesity during menopause
Lizcano, F., & Guzmán, G. (2014) · BioMed Research International · doi:10.1155/2014/757461 · Cited by 586
Menopause-Associated Lipid Metabolic Disorders and Foods Beneficial for Postmenopausal Women
Ko, S.-H., & Kim, H.-S. (2020) · Nutrients · doi:10.3390/nu12010202 · Cited by 516
“There are two types of estrogen receptors: estrogen alpha (ER α) and estrogen beta (ER β) receptors [75].”
BackgroundAllosteric Modulation as a Unifying Mechanism for Receptor Function and Regulation
Changeux, J.-P., & Christopoulos, A. (2016) · Cell · doi:10.1016/j.cell.2016.08.015 · Cited by 336
Nuclear receptors outside the nucleus: extranuclear signalling by steroid receptors
Levin, E. R., & Hammes, S. R. (2016) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm.2016.122 · Cited by 277
Progesterone Receptor Signaling Mechanisms
Grimm, S. L., Hartig, S. M., & Edwards, D. P. (2016) · Journal of Molecular Biology · doi:10.1016/j.jmb.2016.06.020 · Cited by 229
Self-citationSelective glucocorticoid receptor modulation: New directions with non-steroidal scaffolds
Sundahl, N., Bridelance, J., Libert, C., De Bosscher, K., & Beck, I. M. (2015) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2015.05.001 · Cited by 216
“An alternative explanation may reside in different ligand-dependent GR-associated cofactor equilibria, which were shown before to be able to modulate the properties of agonist and antagonist complexes of GR (Wang et al., 2004; Simons et al., 2014).”
BackgroundDNA binding triggers tetramerization of the glucocorticoid receptor in live cells
Presman, D. M., Ganguly, S., Schiltz, R. L., Johnson, T. A., Karpova, T. S., & Hager, G. L. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1606774113 · Cited by 142
“GR is a modular protein organized into three structural and functional domains; the N-terminal ligand-independent activation function-1 domain (NTD), the central DNA-binding domain (DBD), and the C-terminal ligand-binding domain (LBD) (6).”
BackgroundInfluentialGarcia, D. A., Johnson, T. A., Presman, D. M., Fettweis, G., Wagh, K., Rinaldi, L., Stavreva, D. A., Paakinaho, V., Jensen, R. A. M., Mandrup, S., et al. (2021) · Molecular Cell · doi:10.1016/j.molcel.2021.01.013 · Cited by 137
“Equally plausible, TFs with IDRs could adopt a broad distribution of conformations due to the diversity of protein folding (Simons et al., 2014), hence accounting for a broad distribution of binding affinities (Brodsky et al.”
BackgroundGarcia, D. A., Fettweis, G., Presman, D. M., Paakinaho, V., Jarzynski, C., Upadhyaya, A., & Hager, G. L. (2021) · Nucleic Acids Research · doi:10.1093/nar/gkab072 · Cited by 116
Identification of cancer-cytotoxic modulators of PDE3A by predictive chemogenomics
de Waal, L., Lewis, T. A., Rees, M. G., Tsherniak, A., Wu, X., Choi, P. S., Gechijian, L., Hartigan, C., Faloon, P. W., Hickey, M. J., et al. (2016) · Nature Chemical Biology · doi:10.1038/nchembio.1984 · Cited by 96
“New agents including small molecules, antibodies targeting somatic genomic alterations 2 , molecules that impact tissue-specific growth requirements 3 , and immunomodulatory agents 4 , have been shown to benefit a subset of patients whose cancers have unique genomic mutations or other…”
BackgroundHoffman, E. P., Riddle, V., Siegler, M. A., Dickerson, D., Bačkonja, M., Kramer, W. G., Nagaraju, K., Gordish‐Dressman, H., Damsker, J. M., & McCall, J. M. (2018) · Steroids · doi:10.1016/j.steroids.2018.02.010 · Cited by 80
“The modulation of target gene transcription by ligand/receptor steroidal complexes is termed ‘genomic effects’ (also called transactivation) [1].”
BackgroundPorter, B. A., Ortiz, M. A., Bratslavsky, G., & Kotula, L. (2019) · Cancers · doi:10.3390/cancers11121852 · Cited by 91
“This is a common feature found in Class I–III, but not in Class IV [8].”
BackgroundInfluentialC2H2-Type Zinc Finger Proteins: Evolutionarily Old and New Partners of the Nuclear Hormone Receptors
Mackeh, R., Marr, A. K., Fadda, A. A., & Kino, T. (2018) · Nuclear Receptor Signaling · doi:10.1177/1550762918801071 · Cited by 77
“The NTD of NRs is the most variable domain, presumably mediating receptorspecific transcriptional activity through the transactivation domain(s) (activation function-1 [AF-1]) residing in this domain.(15) In contrast, the DBD is highly conserved among NRs and consists of 2 C4-type ZFs through which it directly binds r…”
BackgroundUnraveling the molecular interactions involved in phase separation of glucocorticoid receptor
Stortz, M., Pecci, A., Presman, D. M., & Levi, V. (2020) · BMC Biology · doi:10.1186/s12915-020-00788-2 · Cited by 74
“Particularly, since the IDRs of proteins have been proposed to participate in weak interactions of liquid condensates [13], we analyzed the capability of the GR407C mutant lacking the NTD domain to form foci.”
BackgroundInfluentialComputer-Aided Ligand Discovery for Estrogen Receptor Alpha
Bafna, D., Ban, F., Rennie, P. S., Singh, K., & Cherkasov, A. R. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21124193 · Cited by 77
“It has been found to assume a folded, more orderly state when in contact with certain co-regulators [77].”
BackgroundEstrogen receptor subcellular localization and cardiometabolism
Gourdy, P., Guillaume, M., Fontaine, C., Adlanmérini, M., Montagner, A., Laurell, H., Lenfant, F., & Arnal, J. (2018) · Molecular Metabolism · doi:10.1016/j.molmet.2018.05.009 · Cited by 70
“Steroid binding alters receptor conformation and triggers release from the HSPs, thereby allowing receptor dimerization and translocation in the nucleus where these dimers bind to specific DNA sequences and recruit numerous co-factors to regulate gene transcription [2,3].”
BackgroundAllosteric modulation as a unifying mechanism for receptor function and regulation
Changeux, J., & Christopoulos, A. (2017) · Diabetes Obesity and Metabolism · doi:10.1111/dom.12959 · Cited by 64
More than meets the dimer: What is the quaternary structure of the glucocorticoid receptor?
Presman, D. M., & Hager, G. L. (2016) · Transcription · doi:10.1080/21541264.2016.1249045 · Cited by 60
Burris, T. P., de Vera, I. M. S., Côté, I., Flaveny, C. A., Wanninayake, U. S., Chatterjee, A., Walker, J. K., Steinauer, N., Zhang, J., Coons, L. A., et al. (2023) · Pharmacological Reviews · doi:10.1124/pharmrev.121.000436 · Cited by 56
Self-citationAllosteric small molecule modulators of nuclear receptors
Meijer, F. A., de Gevel, I. A. L.-V., de Vries, R. M. J. M., & Brunsveld, L. (2019) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2019.01.022 · Cited by 54
“At the moment, the most studied allosteric modulators include those that target the activation function 2 (AF-2) cofactor binding site, the DBD or DNA response elements, modulate the receptor dimerization, modulate PTMs or target alternative sites in the LBD.”
InfluentialInfluences of Vitamin A on Vaccine Immunogenicity and Efficacy
Penkert, R. R., Rowe, H. M., Surman, S. L., Sealy, R. E., Rosch, J. W., & Hurwitz, J. L. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01576 · Cited by 54
Receptor-Receptor Interactions as a Widespread Phenomenon: Novel Targets for Drug Development?
Guidolin, D., Marcoli, M., Tortorella, C., Maura, G., & Agnati, L. F. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00053 · Cited by 53
“Mechanisms of structural change from order to disorder (or vice versa), for instance, have been hypothesized to underlie the activation of receptors of the RTK family (144) and intrinsic disorder of the N-terminal domain appears to play a significant role in the functionality of NHRs [see (145)].”
BackgroundEstrogen in vascular smooth muscle cells: A friend or a foe?
Dehaini, H., Fardoun, M., Abou-Saleh, H., EL‐Yazbi, A. F., Eid, A. A., & Eid, A. H. (2018) · Vascular Pharmacology · doi:10.1016/j.vph.2018.09.001 · Cited by 46
Guillaume, M., Handgraaf, S., Fabre, A., Raymond‐Letron, I., Riant, É., Montagner, A., Vinel, A., Buscato, M., Smirnova, N. F., Fontaine, C., et al. (2017) · American Journal Of Pathology · doi:10.1016/j.ajpath.2017.02.013 · Cited by 43
Engström, W., Darbre, P. D., Eriksson, S., Gulliver, L., Hultman, T., Karamouzis, M. V., Klaunig, J. E., Mehta, R., Moorwood, K., Sanderson, J. T., et al. (2015) · Carcinogenesis · doi:10.1093/carcin/bgv030 · Cited by 43
Steroid Receptor Signallings as Targets for Resveratrol Actions in Breast and Prostate Cancer
Amicis, F. D., Chimento, A., Montalto, F. I., Casaburi, I., Sirianni, R., & Pezzi, V. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20051087 · Cited by 38
“steroid receptors are therapeutic targets for specific modulators designed to selectively influence their activity, for various pharmacological purposes [5].”
BackgroundGoswami, D., Callaway, C., Pascal, B. D., Kumar, R., Edwards, D. P., & Griffin, P. R. (2014) · Structure · doi:10.1016/j.str.2014.04.013 · Cited by 40
“Targeting ID proteins by small molecules/peptides to block protein-protein interactions is a rapidly evolving field, and the above findings suggest that compounds that bind to NTD/AF1 could be promising molecules for SR-based therapeutics (Dunker and Uversky, 2010; Ferreon et al., 2013; Simons et al., 2014).”
Self-citationDimerization of glucocorticoid receptors and its role in inflammation and immune responses
Yang, M., Chen, J., & Wei, W. (2020) · Pharmacological Research · doi:10.1016/j.phrs.2020.105334 · Cited by 37
Kumar, P., & Thompson, E. A. (2019) · Biomolecules · doi:10.3390/biom9030095 · Cited by 37
Amador, A., Campbell, S., Kazantzis, M., Lan, G., Burris, T. P., & Solt, L. A. (2018) · PLoS ONE · doi:10.1371/journal.pone.0196787 · Cited by 34
Allosteric pathways in nuclear receptors — Potential targets for drug design
Fernandez, E. J. (2017) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2017.10.014 · Cited by 36
Kumar, R. (2019) · Journal of Cancer · doi:10.7150/jca.32497 · Cited by 31
“Recent studies have shown that unlike DBD and LBD, which exist as globular proteins with well-defined 3-D structure (39), the NTD/AF1 exits as an intrinsically disordered protein (ID), commonly found in many transcription factors including other members of the steroid hormone receptor family (40-42).”
BackgroundSelf-citationAcharya, K. D., Nettles, S. A., Sellers, K. J., Im, D. D., Harling, M., Pattanayak, C. W., Vardar‐Ulu, D., Lichti, C. F., Huang, S., Edwards, D. P., et al. (2017) · eNeuro · doi:10.1523/eneuro.0272-17.2017 · Cited by 23
“PR associate with multiple proteins, including nuclear receptor coactivators, which stabilize the receptor complex and enhance transcription (Hill et al., 2012; Goswami et al., 2014; Simons et al., 2014).”
BackgroundSelf-citationChen, L., Aleshin, A. E., Alitongbieke, G., Zhou, Y., Zhang, X., Ye, X., Hu, M., Ren, G., Chen, Z., Ma, Y., et al. (2017) · Nature Communications · doi:10.1038/ncomms16066 · Cited by 29
Steely, A. M., Willoughby, J. A., Sundar, S. N., Aivaliotis, V. I., & Firestone, G. L. (2017) · Anti-Cancer Drugs · doi:10.1097/cad.0000000000000547 · Cited by 24
Sołtys, K., & Ożyhar, A. (2019) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2019.105571 · Cited by 25
RXRα modulates hepatic stellate cell activation and liver fibrosis by targeting CaMKKβ–AMPKα axis
Cai, L., Yin, M., Peng, S., Fen, L., Lai, L., Zhang, X., Xie, L., Wang, C., Zhou, H., Zhan, Y., et al. (2025) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2025.05.023 · Cited by 22
“The IDR contributes to the complexity of nuclear receptor regulatory networks and cell-and tissue-specific signaling 35-37 .”
Peptidylprolyl Isomerase Pin1 Directly Enhances the DNA Binding Functions of Estrogen Receptor α
Rajbhandari, P., Ozers, M. S., Solodin, N. M., Warren, C. L., & Alarid, E. T. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.621698 · Cited by 23
“An understanding of the interactions in ID domains could provide a mechanistic window to better understand the allosteric role of unstructured domains in transcriptional signaling (26).”
BackgroundProduction of unstable proteins through the formation of stable core complexes
Levy, N., Eiler, S., Pradeau‐Aubreton, K., Maillot, B., Stricher, F., & Ruff, M. (2016) · Nature Communications · doi:10.1038/ncomms10932 · Cited by 24
Kondra, S., Chen, F., Chen, Y., Chen, Y., Collette, C. J., & Xu, W. (2021) · Proteins Structure Function and Bioinformatics · doi:10.1002/prot.26215 · Cited by 16
“Thus, steroid receptors are therapeutic targets for specific modulators designed to selectively influence their activity for various pharmacological purposes.(23) Estrogen, progesterone, and androgen receptors, together with the glucocorticoid and mineralocorticoid receptors, are sex steroid receptors.”
BackgroundSteroid hormone receptors and prostate cancer: role of structural dynamics in therapeutic targeting
Kumar, R. (2016) · Asian Journal of Andrology · doi:10.4103/1008-682x.183380 · Cited by 15
Self-citationRole of nuclear receptors in breast cancer stem cells
Papi, A., & Orlandi, M. (2016) · World Journal of Stem Cells · doi:10.4252/wjsc.v8.i3.62 · Cited by 12
An Approach to Greater Specificity for Glucocorticoids
Chow, C. C., & Simons, S. S. (2018) · Frontiers in Endocrinology · doi:10.3389/fendo.2018.00076 · Cited by 11
Self-citationNehdi, A., Ali, R., Alhallaj, A., Alzahrani, H., Samman, N., Mashhour, A., Baz, O., Barhoumi, T., Alghanem, B., Khan, A., et al. (2019) · Molecules · doi:10.3390/molecules24112028 · Cited by 10
Li, H., Li, X., Yang, B., Su, J., Cai, S., Huang, J., Hu, T., Chen, L., Xu, Y., & Li, Y. (2021) · Scientific Reports · doi:10.1038/s41598-021-96517-y · Cited by 14
Sun, J., Zheng, Q., Zhang, Y., Liu, C., Chen, C., Yan, S.-P., Guo, X.-M., Hu, S., Zhou, Y., & Wu, Y. (2024) · Journal of Saudi Chemical Society · doi:10.1016/j.jscs.2024.101815 · Cited by 10
“LBD is composed of 13 α -helical structures, which can be divided into outer surface dimer binding region, outer surface cofactor binding region, inner surface binding pocket and AF-2 (H12) according to their corresponding functions[12].”
Subair, T. I., Soremekun, O. S., Olotu, F. A., & Soliman, M. E. S. (2021) · Journal of Molecular Modeling · doi:10.1007/s00894-021-04848-4 · Cited by 9
IDPs and their complexes in GPCR and nuclear receptor signaling
Guillien, M., le Maire, A., Mouhand, A., Bernadó, P., Bourguet, W., Banères, J., & Sibille, N. (2020) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2020.05.001 · Cited by 12
Blackford, J. A., Brimacombe, K. R., Dougherty, E. J., Pradhan, M., Shen, M., Li, Z., Auld, D. S., Chow, C. C., Austin, C. P., & Simons, S. S. (2014) · Molecular Endocrinology · doi:10.1210/me.2014-1069 · Cited by 8
Self-citationWięch, A., Tarczewska, A., Ożyhar, A., & Orłowski, M. (2021) · Cells · doi:10.3390/cells10030571 · Cited by 8
Subait, A. A., Alghamdi, R., Ali, R., Alsharidah, A. R., Huwaizi, S. M., Alkhodier, R. A., Almogren, A., Alzomia, B. A., Alaskar, A., & Boudjelal, M. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26020736 · Cited by 8
Protein Condensation in the Nuclear Receptor Family; Implications for Transcriptional Output
Appelman, M. D., Hollaar, E. E., Schuijers, J., & van Mil, S. W. C. (2022) · Advances in experimental medicine and biology · doi:10.1007/978-3-031-11836-4_14 · Cited by 7
Hörberg, J., & Reymer, A. (2023) · Scientific Reports · doi:10.1038/s41598-023-43244-1 · Cited by 7
“GR has a modular structure (25), including two wellcharacterised domains: a ligand-binding domain and a DNA-binding domain.”
BackgroundRole of Protease-Activated Receptors 2 (PAR2) in Ocular Infections and Inflammation
Riggins, R. B. (2014) · Receptors & Clinical Investigation · doi:10.14800/rci.291 · Cited by 9
Khan, S. H., Jasuja, R., & Kumar, R. (2016) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2016.1214086 · Cited by 7
Self-citationPecci, A., Álvarez, L. D., Presman, D. M., & Burton, G. (2016) · Mini-Reviews in Medicinal Chemistry · doi:10.2174/1389557516666160118112313 · Cited by 7
Theory of partial agonist activity of steroid hormones
Chow, C. C., Ong, K. M., Kagan, B. L., & Simons, S. S. (2015) · AIMS molecular science · doi:10.3934/molsci.2015.2.101 · Cited by 6
Self-citationGlucocorticoid Receptor Structure and Function
Kumar, P., & McEwan, I. J. (2015) · Springer eBooks · doi:10.1007/978-3-319-18729-7_3 · Cited by 6
Restored mutant receptor:Corticoid binding in chaperone complexes by trimethylamine N-oxide
Miller, A. L., Elam, W. A., Johnson, B. H., Khan, S. H., Kumar, R., & Thompson, E. B. (2017) · PLOS ONE · doi:10.1371/journal.pone.0174183 · Cited by 5
Self-citationStructural proteomics defines a sequential priming mechanism for the progesterone receptor
Mann, M. D., Wang, M., Ferreon, J. C., Tsoi, P. S., Suess, M. P., Jain, A., Malovannaya, A., Alvarez, R. V., Pascal, B. D., Kumar, P., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-59458-y · Cited by 7
Self-citationDNA ‐induced unfolding of the thyroid hormone receptor α A/B domain through allostery
Fernandez, E. J., Gahlot, V., Rodriguez, C., & Amburn, J. M. (2017) · FEBS Open Bio · doi:10.1002/2211-5463.12229 · Cited by 4
Shamilov, R., & Aneskievich, B. J. (2019) · Nuclear Receptor Research · doi:10.32527/2019/101417 · Cited by 5
Kumar, R. (2021) · General and Comparative Endocrinology · doi:10.1016/j.ygcen.2021.113780 · Cited by 3
Self-citationMechanism of antagonist ligand binding to REV-ERBα
Rahman, M. H., & Hegazy, L. (2024) · Scientific Reports · doi:10.1038/s41598-024-58945-4 · Cited by 4
“Recently, the first X-ray structure of REV-ERBα bound to a synthetic agonist ligand (STL1267) and corepressor peptide has been determined 27 .”
BackgroundCatching the glucocorticoid receptor in the act: Lessons from fluorescence fluctuation methods
Stortz, M., Oses, C., Lafuente, A. L., Presman, D. M., & Levi, V. (2025) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2025.151327 · Cited by 4
Receptors for growth and development of Schistosoma mansoni
Abou-El-Naga, I. F. (2025) · Journal of Helminthology · doi:10.1017/s0022149x24001020 · Cited by 3
“It also contains the dimerization surface and a ligand-dependent transcription activation domain (AF-2) (Simons et al .”
The pERK of being a target: Kinase regulation of the orphan nuclear receptor ERRγ
Riggins, R. B. (2014) · Receptors & Clinical Investigation · doi:10.14800/rci.207 · Cited by 3
Disruption of Other Receptor Systems
Darbre, P. D. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-801139-3.00006-5 · Cited by 3
Cryo-EM technique and its application: Structure of steroid hormone receptors
Kumar, R. A. (2023) · Vitamins and hormones · doi:10.1016/bs.vh.2023.02.002 · Cited by 3
Self-citationShamilov, R., Staid, M. J., & Aneskievich, B. J. (2019) · Methods in molecular biology · doi:10.1007/7651_2019_240 · Cited by 2
Disruption of Other Receptor Systems
Darbre, P. D. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-821985-0.00005-0 · Cited by 2
Statistical Analysis of Protein-Ligand Interaction Patterns in Nuclear Receptor RORγ
Pham, B., Cheng, Z., Lopez, D., Lindsay, R. J., Foutch, D., Majors, R. T., & Shen, T. (2022) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2022.904445 · Cited by 3
Structure and functions of the N-terminal domain of steroid hormone receptors
Kumar, P. (2023) · Vitamins and hormones · doi:10.1016/bs.vh.2023.02.001 · Cited by 2
Estrogen Signaling Based Current and Potential Therapies Against Obesity and Related Diseases
Singh, S. K., & Singh, R. (2021) · Springer eBooks · doi:10.1007/978-981-16-1846-8_15 · Cited by 1
Quarterly intrinsic disorder digest (January-February-March, 2014)
DeForte, S., Reddy, K. D., & Uversky, V. N. (2016) · Intrinsically Disordered Proteins · doi:10.1080/21690707.2016.1153395 · Cited by 1
“argue that structural flexibility is critical in the allosteric modulation of NR activity and discuss the relevance of this to therapeutic interventions.(42)”
BackgroundMosesso, R. (2019) · CaltechTHESIS (California Institute of Technology) · doi:10.7907/x18z-xe16
Kolonko, M., Orłowski, M., & Greb‐Markiewicz, B. (2022) · Kosmos · doi:10.36921/kos.2022_2902
Hörberg, J., & Reymer, A. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.03.15.532803
Structural proteomics defines a sequential priming mechanism for the progesterone receptorPreprint
Mann, M. D., Wang, M., Ferreon, J. C., Suess, M. P., Jain, A., Malovannaya, A., Alvarez, R. V., Pascal, B. D., Kumar, P., Edwards, D. P., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.09.06.611729
Self-citationStructural proteomics defines a sequential priming mechanism for the progesterone receptorPreprint
Griffin, P. R., Mann, M. D., Wang, M., Ferreon, J. C., Suess, M. P., Jain, A., Malovannaya, A., Alvarez, R. V., Pascal, B. D., Kumar, P., et al. (2024) · Research Square · doi:10.21203/rs.3.rs-5199635/v1
Self-citationRole of Glucocorticoid Receptor in Triple-Negative Breast Cancer
Kumar, R. A. (2025) · Receptors · doi:10.3390/receptors4020008
Self-citationMécanisme moléculaires du rôle protumorigénique de PPARgamma et RXRalpha dans les cancers de vessie
Beji, S. (2020) · theses.fr (ABES) · doi:10.70675/99f394a9zdd8bz4cb8z8348z6ada0a583d32
Structural and functional studies of the coregulatory complexes of the vitamin D nuclear receptor
Chalhoub, S. (2020) · theses.fr (ABES) · doi:10.70675/d11221ffz59cez4ebczbd1ezffedb22a0cd5
Kumar, R. (2026) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2026.2671681
“Two activation functions (AFs), constitutively active, AF1 (located within NTD) and ligand-dependent AF2 (located within LBD) serve as transactivation domains and are major sites for critical CoR interactions [6].”
InfluentialSelf-citationOrphan nuclear receptors: structural mechanisms, ligand discovery, and therapeutic potential
Liu, Y., Wei, S., Wang, Z., Yang, H., Chen, Z., Ren, M., & Fu, X. (2026) · Cellular Signalling · doi:10.1016/j.cellsig.2026.112653 · Cited by 2
Rossi, M. C. D., Lareu, A. V., Presman, D. M., & Levi, V. (2026) · International Journal of Biological Macromolecules · doi:10.64898/2026.06.05.730430
“…modular organization of steroid receptors, comprising a central DNA-binding domain (DBD), a C-terminal ligand-binding domain (LBD) separated from the DBD by a flexible hinge region, and two activation function regions (AF1 and AF2) located in the N-terminal domain (NTD) and LBD, respectively [5].”
Guo, X.-J., Zhu, L., Zhou, X., Liang, C., Zhang, X.-L., Wang, C., & Yan, B. (2026) · Journal of Hazardous Materials Advances · doi:10.1016/j.hazadv.2026.101370
Metadata
- Authors
- Simons, S. S., Edwards, D. P., & Kumar, R.
- Affiliations
- National Institutes of Health (US)
- Baylor College of Medicine (US)
- Geisinger College of Health Sciences (US)
- Corresponding author
- Kumar, Raj
- Venue
- Molecular Endocrinology
- Publisher
- The Endocrine Society
- Published
- 2014-02-01
- Volume
- 28
- Issue
- 2
- Pages
- 173-182
- ISSN
- 0888-8809 (ISSN-L)
- 1944-9917
- PMC
- PMC3896641
- OpenAlex
- W1967495043
- Cited by
- 88
- References
- 94
- Citations by year
- 2026: 4 · 2025: 6 · 2024: 4 · 2023: 5 · 2022: 3 · 2021: 9 · 2020: 7 · 2019: 12 · 2018: 6 · 2017: 8 · 2016: 12 · 2015: 7 · 2014: 5
- FWCI
- 0.75
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Molecular Endocrinology (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Cancer Institute (CA046938, R01CA046938)
- National Institute of Diabetes and Digestive and Kidney Diseases (DK049030, R01DK049030)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Structure and Dynamics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Endocrinology › Estrogen and related hormone effects
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Receptor Mechanisms and Signaling
- Keywords
- nuclear receptors, intrinsically disordered regions, N-terminal domain, activation functions, AF-2, ligand-binding domain, allosteric modulation, structural flexibility
- MeSH terms
- Allosteric Regulation, Animals, Humans, Neoplasms, Protein Conformation, Transcriptional Activation, Receptors, Cytoplasmic and Nuclear, Molecular Targeted Therapy, Intrinsically Disordered Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.